← Olin overview

Olin vs Solstice Advanced Materials: why the prices moved differently

Weekly · monthly · quarterly news summaries, side by side in time

Olin Corporation (OLN)

Q3 2026
▲2▼2

Olin's Huntsman merger advances amid weak demand and a Q2 loss

  • Huntsman merger clears key hurdles Olin's all-stock merger with Huntsman won shareholder approval and passed U.S. antitrust review. The deal targets $300–400 million in cost savings and could add $8–11 per share, though integration risks remain.

    This is the biggest new corporate event that could reshape Olin and lift its value.

  • Weak chemicals demand causes surprise Q2 loss Soft demand for chemicals led to an unexpected second-quarter loss, sending the stock down 16% in one day. The company also gave weak third-quarter profit guidance of $160–200 million.

    This was the main negative shock that drove the stock lower during the period.

  • Epoxy and Winchester sales lift profit Strong sales in Epoxy and Winchester businesses helped adjusted EBITDA rise 8.6% to $191.3 million. A tightening chlor-alkali market could also benefit Olin over the long term.

    These bright spots show parts of the business are performing well despite overall weakness.

  • Analyst downgrade and plant disruption Citi cut its price target to $17, pointing to broad weakness in the chemicals sector. A disruption at Olin's Freeport plant added to operational concerns.

    These events reinforced negative sentiment and highlighted ongoing challenges.

August 2026
▲2▼2

Olin's Huntsman merger advances, but weak chemicals demand and losses weigh

  • Weak Q2 results and soft Q3 guidance Olin posted a wider second-quarter loss of $13.3 million as sales slipped 0.9% to $1.74 billion, and guided third-quarter EBITDA to $160–200 million, including a roughly $20 million hit from a Freeport plant disruption. Weak profits and guidance pressure the stock.

    This is the core earnings reality that sets the baseline for OLN's price this period.

  • Huntsman merger clears key hurdles Shareholders of both companies approved the all-stock merger on August 25, and the U.S. antitrust waiting period expired in September. The deal would create a larger chemicals platform with $300 million in planned cost savings, a major potential boost for Olin.

    The merger is the biggest company-specific catalyst driving OLN's outlook and valuation.

  • Epoxy and Winchester strength offset chlor alkali weakness Epoxy sales jumped 27.4% and Winchester ammunition sales rose 11.8%, lifting adjusted EBITDA 8.6% to $191.3 million and beating revenue expectations. These growing businesses are helping cushion the decline in the larger chlor alkali and vinyls segment.

    It shows which parts of Olin are actually growing and supporting profits despite overall weakness.

  • Citi cuts price target on weak chemical demand Citi kept a Neutral/High Risk rating on Olin and lowered its price target to $17 from $19, citing weak demand that is limiting gains from higher oil and feedstock costs. It also cut targets across many North American chemical peers, signaling broad sector pressure.

    This is the latest analyst view showing demand headwinds that could keep OLN's stock under pressure.

Latest
▲2▼2

Olin's Huntsman merger advances, but weak chemicals demand and losses weigh

  • Weak Q2 results and soft Q3 guidance Olin posted a wider second-quarter loss of $13.3 million as sales slipped 0.9% to $1.74 billion, and guided third-quarter EBITDA to $160–200 million, including a roughly $20 million hit from a Freeport plant disruption. Weak profits and guidance pressure the stock.

    This is the core earnings reality that sets the baseline for OLN's price this period.

  • Huntsman merger clears key hurdles Shareholders of both companies approved the all-stock merger on August 25, and the U.S. antitrust waiting period expired in September. The deal would create a larger chemicals platform with $300 million in planned cost savings, a major potential boost for Olin.

    The merger is the biggest company-specific catalyst driving OLN's outlook and valuation.

  • Epoxy and Winchester strength offset chlor alkali weakness Epoxy sales jumped 27.4% and Winchester ammunition sales rose 11.8%, lifting adjusted EBITDA 8.6% to $191.3 million and beating revenue expectations. These growing businesses are helping cushion the decline in the larger chlor alkali and vinyls segment.

    It shows which parts of Olin are actually growing and supporting profits despite overall weakness.

  • Citi cuts price target on weak chemical demand Citi kept a Neutral/High Risk rating on Olin and lowered its price target to $17 from $19, citing weak demand that is limiting gains from higher oil and feedstock costs. It also cut targets across many North American chemical peers, signaling broad sector pressure.

    This is the latest analyst view showing demand headwinds that could keep OLN's stock under pressure.

July 2026
▲2▼1

Olin's merger advances, but weak chemicals demand and a surprise loss weigh on the stock

  • Olin-Huntsman merger approved by shareholders Shareholders overwhelmingly approved the all-stock merger with Huntsman, creating a $12.5 billion chemicals company. The deal promises over $400 million in cost savings, which could boost future profits and support the stock. It is expected to close in the first half of 2027, pending regulatory approval.

    This is the latest major step in the merger and directly affects OLN's future value.

  • Surprise Q2 loss and 16% stock drop Olin reported a surprise loss of $0.12 per share, missing expectations for a profit, and revenue fell short. The stock dropped about 16% in one day. Weak chlor alkali sales and merger-related costs drove the loss, showing the company's core business is struggling.

    This is a new negative event that directly caused a sharp price decline and reflects fundamental weakness.

  • Chlor-alkali market tightening could lift Olin Hotchkis & Wiley sees North American chlor-alkali supply and demand tightening over the next five-plus years, which could raise prices and volumes. As the region's swing producer, Olin could benefit more than peers. This long-term trend offers a potential recovery path.

    This is a new analyst view on a key market driver that could improve Olin's future earnings.

  • Merger synergies valued, but integration costs and risks remain UBS estimates the merger's cost savings could add $8–$11 per share in value, mainly from procurement, operations, and overhead cuts. However, the deal also brings $10.6 million in acquisition costs and execution risk, and it does not expand into new markets, so the benefit depends on successful integration.

    This explains the financial rationale and potential value of the merger, a key driver for OLN.

▲2▼1

Olin's merger advances, but weak chemicals demand and a surprise loss weigh on the stock

  • Olin-Huntsman merger approved by shareholders Shareholders overwhelmingly approved the all-stock merger with Huntsman, creating a $12.5 billion chemicals company. The deal promises over $400 million in cost savings, which could boost future profits and support the stock. It is expected to close in the first half of 2027, pending regulatory approval.

    This is the latest major step in the merger and directly affects OLN's future value.

  • Surprise Q2 loss and 16% stock drop Olin reported a surprise loss of $0.12 per share, missing expectations for a profit, and revenue fell short. The stock dropped about 16% in one day. Weak chlor alkali sales and merger-related costs drove the loss, showing the company's core business is struggling.

    This is a new negative event that directly caused a sharp price decline and reflects fundamental weakness.

  • Chlor-alkali market tightening could lift Olin Hotchkis & Wiley sees North American chlor-alkali supply and demand tightening over the next five-plus years, which could raise prices and volumes. As the region's swing producer, Olin could benefit more than peers. This long-term trend offers a potential recovery path.

    This is a new analyst view on a key market driver that could improve Olin's future earnings.

  • Merger synergies valued, but integration costs and risks remain UBS estimates the merger's cost savings could add $8–$11 per share in value, mainly from procurement, operations, and overhead cuts. However, the deal also brings $10.6 million in acquisition costs and execution risk, and it does not expand into new markets, so the benefit depends on successful integration.

    This explains the financial rationale and potential value of the merger, a key driver for OLN.

Solstice Advanced Materials, Inc (SOLS)

Q3 2026
▲2▼1

Solstice's $14.5B Deal Scrapped, Buyback and Strong Q2 Lift Shares

  • Element Solutions Acquisition and Termination Solstice's $14.5B deal for Element Solutions initially sank shares 15% on dilution and debt worries, but was later terminated after shareholder pushback, removing a major overhang.

    This was the biggest event of the quarter, causing a sharp drop and then relief.

  • Strong Q2 Results and Raised Guidance Solstice reported Q2 sales of $1.15B, up 11%, and raised its full-year guidance, signaling robust demand and operational momentum.

    Strong financial results and improved outlook are key positive drivers for the stock.

  • First-Ever $500M Buyback The company announced its first-ever $500M share buyback, a move that can boost earnings per share and shows confidence in future cash flows.

    Buybacks often lift stock prices by reducing share count and signaling management optimism.

  • Secular Growth vs. Analyst Caution Growth drivers in uranium conversion and AI/semiconductor materials are promising, but analysts are split: BMO cut its target to $83, and UBS warned higher rates and weak sector growth could limit gains.

    This captures the tug-of-war between long-term opportunities and near-term headwinds.

August 2026
▲3

Solstice Goes Standalone After Deal Collapse, Q2 Beats

  • Element Solutions merger terminated Solstice called off its $14.5 billion merger with Element Solutions after shareholders objected. The move removes a major overhang that had weighed on the stock, as investors had worried about dilution and debt from the deal.

    The termination is a major new event that directly affects Solstice's ownership and capital structure.

  • Strong Q2 results and raised guidance Solstice reported second-quarter sales of $1.15 billion, up 11% from a year earlier, and raised its full-year 2026 guidance. The results show the standalone business is growing faster than expected, supporting the bull case.

    Q2 earnings and guidance are fresh fundamental data that can drive investor confidence and price.

  • First-ever $500 million buyback Solstice announced its first-ever share buyback program of $500 million. Buybacks reduce the number of shares outstanding, which can boost earnings per share and signal management's confidence in the company's future.

    A new capital return program is a concrete action that can support the stock price.

  • Analyst split and macro headwinds After the deal collapse, BMO cut its price target to $83 from $95 but kept a Buy rating. UBS added Solstice to its industrial capex list with an $80 target, yet warned higher interest rates and weak sector growth could limit gains.

    Analyst reactions and macro warnings provide a balanced view of the risks and rewards ahead.

Latest
▲4

Solstice Kills $14.5B Deal, Goes Independent With Buyback and R&D Push

  • Solstice scraps $14.5B Element deal, stays independent Solstice and Element Solutions mutually ended their $14.5 billion merger after shareholders pushed for independence, with no breakup fee. The deal had dragged Solstice shares down, so walking away removes that overhang. Solstice also reaffirmed raised guidance and reported second-quarter sales up 11% to $1.148 billion.

    The termination is the single biggest new event and reverses the deal that had been weighing on the stock.

  • First-ever $500 million buyback authorized Solstice's board approved its first-ever share buyback of up to $500 million. Buying back stock can lift the share price by shrinking the number of shares and signaling management believes the stock is undervalued. It also puts the company's cash to work after staying independent.

    A new capital-return action that directly supports the share price and shows confidence.

  • UBS adds Solstice to industrial capital-spending list UBS named Solstice one of 10 industrial stocks set to benefit from a broader capital-spending cycle, with an $80 price target. That implies meaningful upside and draws investor attention to Solstice as manufacturing demand recovers. UBS flagged higher interest rates and weak growth as risks to the sector.

    A fresh analyst endorsement that frames Solstice as a beneficiary of an improving industrial cycle.

  • $49 million Buffalo R&D expansion with state support Solstice will invest $49 million to expand its Buffalo research campus, backed by up to $1.4 million in New York tax credits. The project adds labs for refrigerants, thermal management and energy storage, plus 12 new jobs by June 2027. It signals long-term growth investment in its core businesses.

    A concrete new investment showing Solstice is funding future growth after the deal fell through.

▲3

Solstice Goes It Alone: Merger Scrapped, Buyback and Guidance Lift Stock

  • Standalone pure-play after Honeywell breakup Honeywell finished splitting into four companies, leaving Solstice as a standalone specialty materials business focused on refrigerants and nuclear materials. Investors often pay more for a focused company than a conglomerate piece, which can lift the shares over time.

    This is the structural event that created SOLS as an independent stock and frames all later news.

  • Strong Q2 and raised 2026 guidance Solstice's second-quarter sales rose 11% to $1.15 billion, beating its own forecast, and it raised full-year sales and profit guidance. Management said the heaviest plant maintenance is done, which should help margins in the second half.

    Better-than-expected results and higher guidance are a direct, fundamental reason the stock can rise.

  • Merger with Element Solutions terminated; $500M buyback Solstice and Element Solutions called off their $14.5 billion merger with no fees, after shareholder pushback. Solstice then authorized its first $500 million share buyback and kept its 2026 sales guidance, sending the stock up 12.8% as investors welcomed the standalone path.

    This is the period's biggest new event and the main reason SOLS moved sharply higher.

  • Analyst views split after the deal collapse UBS had upgraded Solstice to Buy in July, saying the stock was undervalued and could grow earnings about 18% a year. After the merger ended, BMO cut its price target to $83 from $95 but kept a Buy rating, showing support but also caution about the standalone plan.

    It shows the real counterweight: analysts still see value but have trimmed expectations after the merger fell through.

July 2026
▲3▼1

Solstice's $14.5B Element Deal Shakes Stock, But Growth Story Intact

  • Solstice to acquire Element Solutions for $14.5B, shares drop 15% Solstice announced a $14.5 billion cash-and-stock deal to buy Element Solutions, sending its shares down nearly 15%. The deal dilutes existing shareholders and adds debt, which worries investors. The market's negative reaction shows concern about the price paid and integration risks.

    This is the major new event that directly caused a sharp stock drop and dominates the period.

  • CEO and Cramer defend deal, call pullback a buying opportunity Solstice's CEO said Wall Street misread the deal, blaming hedge funds and arbitrage traders for the sell-off. Jim Cramer called the merger 'very smart' and the pullback a 'terrific buying opportunity.' These endorsements may boost investor confidence and support a price recovery.

    This is new this period and provides a counterweight to the negative market reaction, potentially influencing price direction.

  • Solstice's uranium conversion and AI materials demand drive growth Solstice is the sole US utility-scale provider of uranium conversion services, with strengthening demand prompting capacity expansion. It also supplies specialty materials for AI data centers and semiconductors, benefiting from surging demand. These secular growth drivers underpin the long-term investment case.

    This explains the fundamental demand forces behind Solstice's growth story, which is key to understanding its valuation.

  • Solstice stock up 66% since spinoff, trades at premium valuation Since spinning off from Honeywell nine months ago, Solstice shares have surged about 66%, trading at 30 times forward earnings with expected earnings growth over 20%. The company offers exposure to AI and nuclear energy themes, attracting investor interest despite the recent pullback.

    This provides context on the stock's strong performance and valuation, helping investors assess the current opportunity.

▲3▼1

Solstice's $14.5B Element Deal Shakes Stock, But Growth Story Intact

  • Solstice to acquire Element Solutions for $14.5B, shares drop 15% Solstice announced a $14.5 billion cash-and-stock deal to buy Element Solutions, sending its shares down nearly 15%. The deal dilutes existing shareholders and adds debt, which worries investors. The market's negative reaction shows concern about the price paid and integration risks.

    This is the major new event that directly caused a sharp stock drop and dominates the period.

  • CEO and Cramer defend deal, call pullback a buying opportunity Solstice's CEO said Wall Street misread the deal, blaming hedge funds and arbitrage traders for the sell-off. Jim Cramer called the merger 'very smart' and the pullback a 'terrific buying opportunity.' These endorsements may boost investor confidence and support a price recovery.

    This is new this period and provides a counterweight to the negative market reaction, potentially influencing price direction.

  • Solstice's uranium conversion and AI materials demand drive growth Solstice is the sole US utility-scale provider of uranium conversion services, with strengthening demand prompting capacity expansion. It also supplies specialty materials for AI data centers and semiconductors, benefiting from surging demand. These secular growth drivers underpin the long-term investment case.

    This explains the fundamental demand forces behind Solstice's growth story, which is key to understanding its valuation.

  • Solstice stock up 66% since spinoff, trades at premium valuation Since spinning off from Honeywell nine months ago, Solstice shares have surged about 66%, trading at 30 times forward earnings with expected earnings growth over 20%. The company offers exposure to AI and nuclear energy themes, attracting investor interest despite the recent pullback.

    This provides context on the stock's strong performance and valuation, helping investors assess the current opportunity.